GOLPH3 and gastric cancer: Serum GOLPH3 concentrations in GC patients at each individual stage (II-IV) were significantly higher than those in healthy controls (all P < 0.001, Figure 3(a)), though there was no significant difference between patients at stage I and healthy controls.